You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大行評級丨花旗:上調鉅子生物目標價至93.7港元 618大促在天貓平臺開局良好
花旗發表報告指,鉅子生物公司618大促在天貓平臺開局良好,排名顯著提升。該行預計增長動能將來自新客戶(佔客戶羣的60%至70%)及新產品組合——明星產品膠原棒升級推動客單價提升20%,專注修護霜銷售額佔比從原低中單位數攀升至中高單位數。管理層現階段維持2025年業績指引,將待持續至6月末的大促最終結果出爐後再做評估。該行上調對其今年至2027年各年盈測介乎5%至18%,以反映收入預測被上調,目標價由原先78.1港元上調至93.7港元,相當於預測今年市盈率由原先28倍升至34倍,反映增長展望更佳,並與內地同業估值倍數一致,並維持“買入”評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account